Co-Diagnostics Completes Submission to FDA for PCR COVID Test
Co-Diagnostics submitted its Co-Dx PCR COVID-19 test for review by the U.S. FDA for Emergency Use Authorization (EUA).
Read MorePosted by Andy Lundin | Dec 27, 2023 | Covid 19 |
Co-Diagnostics submitted its Co-Dx PCR COVID-19 test for review by the U.S. FDA for Emergency Use Authorization (EUA).
Read MorePosted by Andy Lundin | Dec 25, 2023 | Covid 19 |
This collaboration aims to use the ViraxImmune IVD platform to improve the understanding of T-Cell immune response in COVID patients.
Read MorePosted by Andy Lundin | Dec 22, 2023 | Covid 19 |
A new study found that brain injury markers are present in the blood months after COVID infection, despite normal inflammation blood tests.
Read MorePosted by Andy Lundin | Dec 21, 2023 | Molecular Diagnostics, Sexually Transmitted Diseases |
QuidelOrtho received 510(K) clearance from the FDA for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test
Read MorePosted by Andy Lundin | Dec 18, 2023 | Molecular Diagnostics |
GRIP and Molecular Testing Labs collaborated on a electronic biosensor platform to provide lab-quality testing results for consumers.
Read More